These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26226472)

  • 21. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
    Palioura S; Kim B; Dohlman CH; Chodosh J
    Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography.
    Garcia JP; Ritterband DC; Buxton DF; De la Cruz J
    Cornea; 2010 Sep; 29(9):1031-5. PubMed ID: 20517152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon?
    Nouri M; Durand ML; Dohlman CH
    Cornea; 2005 Nov; 24(8):915-9. PubMed ID: 16227832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Outcome of combined penetrating keratoplasty with vitreoretinal surgery using temporary Eckardt keratoprosthesis].
    Levy J; Kratz A; Klemperer I; Lifshitz T
    Harefuah; 2005 Nov; 144(11):781-4, 822. PubMed ID: 16358653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography.
    Fernandez AG; Radcliffe NM; Sippel KC; Rosenblatt MI; Sood P; Starr CE; Ciralsky JB; D'Amico DJ; Kiss S
    Clin Ophthalmol; 2012; 6():1355-9. PubMed ID: 22969280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization.
    Kiang L; Rosenblatt MI; Sartaj R; Fernandez AG; Kiss S; Radcliffe NM; D'Amico DJ; Sippel KC
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1195-9. PubMed ID: 22371021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anterior segment optical coherence tomography for the quantitative evaluation of the anterior segment following Boston keratoprosthesis.
    Kang JJ; Allemann N; Vajaranant TS; Vajaranant T; de la Cruz J; Cortina MS
    PLoS One; 2013; 8(8):e70673. PubMed ID: 23940621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric keratoprosthesis.
    Aquavella JV; Gearinger MD; Akpek EK; McCormick GJ
    Ophthalmology; 2007 May; 114(5):989-94. PubMed ID: 17467531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and management of patients with Boston type 1 keratoprosthesis explantation--the University of Montreal Hospital Center experience.
    Wang Q; Harissi-Dagher M
    Am J Ophthalmol; 2014 Dec; 158(6):1297-1304.e1. PubMed ID: 25174898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Boston keratoprosthesis in herpetic keratitis.
    Khan BF; Harissi-Dagher M; Pavan-Langston D; Aquavella JV; Dohlman CH
    Arch Ophthalmol; 2007 Jun; 125(6):745-9. PubMed ID: 17562983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
    Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
    Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial Analysis of Anterior Chamber Depth and Angle Status Using Anterior Segment Optical Coherence Tomography After Boston Keratoprosthesis.
    Kang JJ; Allemann N; Cruz Jde L; Cortina MS
    Cornea; 2013 Oct; 32(10):1369-74. PubMed ID: 23974896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitreoretinal complications of the Boston Keratoprosthesis.
    Modjtahedi BS; Eliott D
    Semin Ophthalmol; 2014; 29(5-6):338-48. PubMed ID: 25325859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis.
    Ramchandran RS; Diloreto DA; Chung MM; Kleinman DM; Plotnik RP; Graman P; Aquavella JV
    Ophthalmology; 2012 Apr; 119(4):674-81. PubMed ID: 22266108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
    Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
    Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.